Continue Reading FDA Seeks Comments on Revised Draft Guidance for Communicating Scientific Information on Unapproved Uses of Approved/Cleared Medical Products
  • Yesterday, Janet Woodcock, M.D., the Principle Deputy Commissioner for the Office of the FDA Commissioner, released a statement regarding the Agency’s approach towards cannabidiol (CBD) and its application in the
Continue Reading FDA Concludes that New Regulatory Frameworks for Foods and Supplements Containing Cannabidiol are Needed, Will Work with Congress